AREV Life Sciences Global Corp.
AREVF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $158 | $298 | $30 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $49 | $129 | $26 | $3 |
| Inventory | $0 | $20 | $5 | $0 |
| Other Curr. Assets | $0 | $0 | $515 | $19 |
| Total Curr. Assets | $67 | $338 | $858 | $86 |
| Property Plant & Equip (Net) | $186 | $284 | $419 | $794 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $13 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | -$13 |
| Total NC Assets | $186 | $284 | $419 | $794 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $253 | $623 | $1,277 | $879 |
| Liabilities | – | – | – | – |
| Payables | $805 | $476 | $433 | $307 |
| Short-Term Debt | $29 | $23 | $636 | $573 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | -$36 | $0 | $0 |
| Total Curr. Liab. | $1,205 | $716 | $1,866 | $1,405 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $52 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $52 | $100 | $0 |
| Total Liabilities | $1,205 | $716 | $1,918 | $1,405 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13,667 | $13,154 | $12,045 | $11,315 |
| Retained Earnings | -$17,548 | -$16,104 | -$15,113 | -$14,065 |
| AOCI | $101 | $2,857 | $0 | $0 |
| Other Equity | $2,827 | $0 | $2,427 | $2,223 |
| Total Equity | -$953 | -$94 | -$641 | -$526 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $253 | $623 | $1,277 | $879 |
| Net Debt | $29 | -$135 | $339 | $544 |